Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice

Inflammatory Bowel Diseases

Volumn 8, Issue 2, 2002, Pages 71-80

  Schultz, Michael ^a,b   Veltkamp, Claudia ^a   Dieleman, Levinus A ^a   Grenther, Wetonia B ^c   Wyrick, Pricilla B ^a   Tonkonogy, Susan L ^c   Balfour Sartor, R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Experimental colitis; Interleukin 10 knockout mice; Probiotics

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 12; LACTOBACILLUS VACCINE; LIVE VACCINE; PROBIOTIC AGENT; PROTEIN P40;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CLINICAL PROTOCOL; COLITIS; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; ENTERITIS; GERMFREE ANIMAL; HISTOPATHOLOGY; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; INTERFERON PRODUCTION; LACTOBACILLUS PLANTARUM; MESENTERY LYMPH NODE; MICROBIAL ATTENUATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0036198391     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200203000-00001     Document Type: Article

References (66)

1. Inflammatory bowel disease: Etiology and pathogenesis
2. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation
3. Intestinal microflora in human and experimental inflammatory bowel disease
4. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats
5. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation
6. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice
7. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment
8. Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tgε26 mice
9. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain
10. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice
11. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice
12. A novel model of inflammatory bowel disease: Mice deficient for the multiple drug resistance gene, mdrla, spontaneously develop colitis
13. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon
14. Double blind, placebo controlled trial of metronidazole in Crohn's disease
15. Long-term treatment of ulcerative colitis with ciprofloxacin: A prospective, double-blind, placebo-controlled study
16. T cell specificity and cross reactivity towards Enterobacteria, Bacteroides, Bifidobacterium, and antigens from resident intestinal flora in humans
17. CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease
18. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls
19. The assessment of fecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique
20. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat
21. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease
22. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
23. The effect of probiotics on Clostridium difficile diarrhea
24. Efficacy of Lactobacillus GG as a diarrheal preventative in travelers
25. Prevention of traveler's diarrhea by Lactobacillus GG
26. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children
27. Probiotics and infectious diarrhea
28. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
29. Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis
30. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
31. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial
32. Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine
33. Probiotics and inflammatory bowel diseases
34. Probiotics in inlfammatory bowel disease
35. The role of probiotic cultures in the control of gastro-intestinal health
36. Adhesion of Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells
37. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression
38. Lactobacillus casei strain GG reverses increased permeability induced by cow milk in suckling rats
39. Clinical uses of probiotics for stabilizing the gut mucosal barrier: Successful strains and future challenges
40. Lactobacillus species prevents colitis in interleukin-10 gene-deficient mice
41. Antimicrobial substance from a human Lactobacillus strain
42. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats
43. Elevated IL-10 levels in pouch-tissue after probiotic therapy
44. Probiotics and immune response
45. Oral administration of Lactobacillus GG (L. GG) induces an antiinflammatory, TH-2 mediated systemic immune response towards intestinal organisms
46. Bifidobacterium is a strong stimulant for IgA antibody production by mucosal B lymphocytes
47. Expression of cytokines, inducible nitric oxide synthetase and matrix metalloproteinases in pouchitis: Effects of probiotic treatment
48. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria
49. Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: Evidence of NK cells as primary targets
50. Interleukin-10-deficient mice develop chronic enterocolitis
51. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
52. Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats
53. Fecal PCR assay for diagnosis of Helicobacter infection in laboratory rodents
54. 3H/HeJ Bir mice exhibiting spontaneous perianal ulceration
55. Administration of different Lactobacillus strains in fermented oatmeal soup: In vivo colonization of human intestinal mucosa and effect on the indigenous flora
56. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats
57. Lactobacillus plantarum is superior to Lactobacillus GG in preventing colitis in IL-10 deficient mice
58. 27 transgenic rats after antibiotic treatment
59. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli
60. IL-10 deficient mice monoassociated with non-pathogenic Enterococcus faecalis develop chronic colitis
61. Helicobacter hepaticus does not induce or perpetuate colitis in interleukin-10-deficient mice
62. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination
63. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
64. Bacterial DNA induced murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α
65. The evolution and genetics of innate immunity
66. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain